Literature DB >> 5642916

Retinoblastoma and iris neovascularization.

D S Walton, W M Grant.   

Abstract

Entities:  

Mesh：

Year:  1968        PMID： 5642916     DOI： 10.1016/0002-9394(68)93882-8

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  8 in total

1.  Fibroblast radiosensitivity and intraocular fibrovascular proliferation following radiotherapy for bilateral retinoblastoma.

Authors:  D M Albert; D S Walton; R R Weichselbaum; J R Cassady; J B Little; D Leombruno; R Trantravahi; C A Puliafito
Journal:  Br J Ophthalmol       Date:  1986-05       Impact factor: 4.638

2.  Astrocytoma of the retina. Report of a case.

Authors:  J Jordano; H Galera; M Toro; B Carreras
Journal:  Br J Ophthalmol       Date:  1974-05       Impact factor: 4.638

3.  Malignant melanoma and rubeosis iridis. Histopathological and statistical study.

Authors:  J M Cappin
Journal:  Br J Ophthalmol       Date:  1973-11       Impact factor: 4.638

4.  An approach to the management of neovascularization of the iris and secondary glaucoma.

Authors:  S J Ryan
Journal:  Trans Am Ophthalmol Soc       Date:  1980

5.  Rubeosis iridis in retinoblastoma and pseudoglioma.

Authors:  G Spaulding
Journal:  Trans Am Ophthalmol Soc       Date:  1978

6.  Retinoblastoma: correlation of invasion of the optic nerve and choroid with prognosis and metastases.

Authors:  C Stannard; S Lipper; R Sealy; D Sevel
Journal:  Br J Ophthalmol       Date:  1979-08       Impact factor: 4.638

Review 7.  Neovascular Glaucoma.

Authors:  Shane J Havens; Vikas Gulati
Journal:  Dev Ophthalmol       Date:  2015-10-26

8.  Gelatinase expression in retinoblastoma: modulation of LH(BETA)T(AG) retinal tumor development by anecortave acetate.

Authors:  M Livia Bajenaru; Yolanda Piña; Timothy G Murray; Colleen M Cebulla; William Feuer; Maria-Elena Jockovich; Maria-Encarna Marin Castaño
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-27       Impact factor: 4.799
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.